WeightWatchers shares soared after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
WeightWatchers shares soared Tuesday after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
Ozempic, also known as semaglutide, works by stimulating the body's own insulin production and reducing appetite. While it is prescribed for diabetes, Ozempic can also help people lose weight. The weight loss side effect of Ozempic has recently caused the drug to go viral on social media, with some people now seeking prescriptions from their doctors for that off-label use.
If it's not treated, obesity can lead to lifelong health problems, including high blood pressure, diabetes and depression.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
WeightWatchers buys telehealth platform Sequence, facilitating access to Ozempic and WegovyThe diet company is hoping to offer members the ability to meet with clinicians who can prescribe obesity and diabetes medications.
Weiterlesen »
WSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
Weiterlesen »
WeightWatchers Bets on So-Called Miracle Obesity Drug Ozempic in New Deal: ReportThe Wall Street Journal reported Monday that WeightWatchers is buying a telehealth subscription service called Sequence, which allows doctors to prescribe both Ozempic and its sister drug, Wegovy.
Weiterlesen »
WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
Weiterlesen »
WeightWatchers prescription med move causes concern for those who need Ozempic for type 2 diabetesWeightWatchers shares soared after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
Weiterlesen »
WeightWatchers Is Getting In on the Ozempic BoomThe company acquired telehealth provider Sequence, which prescribes weight-loss drugs, for $106 million.
Weiterlesen »